Biomaterial implants mediate autologous stem cell recruitment in mice

A. Nair, J. Shen, P. Lotfi, C. Y. Ko, Chengcheng Zhang, L. Tang

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Autologous stem cells, recognized as the best cells for stem cell therapy, are associated with difficult extraction procedures which often lead to more traumas for the patients and time-consuming laboratory work, which delays their subsequent application. To combat such challenges, it was recently uncovered that, shortly after biomaterial implantation, following the recruitment of inflammatory cells, substantial numbers of mesenchymal stem cells (MSC) and hematopoietic stem cells (HSC) were recruited to the implantation sites. These multipotent MSC could be differentiated into various lineages in vitro. Inflammatory signals may be responsible for the gathering of stem cells, since there is a good relationship between biomaterial-mediated inflammatory responses and stem cell accumulation in vivo. In addition, the treatment with the anti-inflammatory drug dexamethasone substantially reduced the recruitment of both MSC and HSC. The results from this work support that such strategies could be further developed towards localized recruitment and differentiation of progenitor cells. This may permit the future development of autologous stem cell therapies without the need for tedious cell isolation, culture and transplantation.

Original languageEnglish (US)
Pages (from-to)3887-3895
Number of pages9
JournalActa Biomaterialia
Volume7
Issue number11
DOIs
StatePublished - Nov 2011

Fingerprint

Biocompatible Materials
Stem cells
Biomaterials
Stem Cells
Mesenchymal Stromal Cells
Cell- and Tissue-Based Therapy
Hematopoietic Stem Cells
Multipotent Stem Cells
Cell Separation
Cell Transplantation
Dexamethasone
Anti-Inflammatory Agents
Cell Culture Techniques
Cell Count
Cell culture
Wounds and Injuries
Pharmaceutical Preparations

Keywords

  • Autologous stem cells
  • Flow cytometry
  • Foreign body response
  • Hematopoietic stem cells
  • Mesenchymal stem cells

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Biotechnology
  • Biochemistry
  • Molecular Biology

Cite this

Biomaterial implants mediate autologous stem cell recruitment in mice. / Nair, A.; Shen, J.; Lotfi, P.; Ko, C. Y.; Zhang, Chengcheng; Tang, L.

In: Acta Biomaterialia, Vol. 7, No. 11, 11.2011, p. 3887-3895.

Research output: Contribution to journalArticle

Nair, A. ; Shen, J. ; Lotfi, P. ; Ko, C. Y. ; Zhang, Chengcheng ; Tang, L. / Biomaterial implants mediate autologous stem cell recruitment in mice. In: Acta Biomaterialia. 2011 ; Vol. 7, No. 11. pp. 3887-3895.
@article{b5dc91ccf56d4e1e83376a725677e7a6,
title = "Biomaterial implants mediate autologous stem cell recruitment in mice",
abstract = "Autologous stem cells, recognized as the best cells for stem cell therapy, are associated with difficult extraction procedures which often lead to more traumas for the patients and time-consuming laboratory work, which delays their subsequent application. To combat such challenges, it was recently uncovered that, shortly after biomaterial implantation, following the recruitment of inflammatory cells, substantial numbers of mesenchymal stem cells (MSC) and hematopoietic stem cells (HSC) were recruited to the implantation sites. These multipotent MSC could be differentiated into various lineages in vitro. Inflammatory signals may be responsible for the gathering of stem cells, since there is a good relationship between biomaterial-mediated inflammatory responses and stem cell accumulation in vivo. In addition, the treatment with the anti-inflammatory drug dexamethasone substantially reduced the recruitment of both MSC and HSC. The results from this work support that such strategies could be further developed towards localized recruitment and differentiation of progenitor cells. This may permit the future development of autologous stem cell therapies without the need for tedious cell isolation, culture and transplantation.",
keywords = "Autologous stem cells, Flow cytometry, Foreign body response, Hematopoietic stem cells, Mesenchymal stem cells",
author = "A. Nair and J. Shen and P. Lotfi and Ko, {C. Y.} and Chengcheng Zhang and L. Tang",
year = "2011",
month = "11",
doi = "10.1016/j.actbio.2011.06.050",
language = "English (US)",
volume = "7",
pages = "3887--3895",
journal = "Acta Biomaterialia",
issn = "1742-7061",
publisher = "Elsevier BV",
number = "11",

}

TY - JOUR

T1 - Biomaterial implants mediate autologous stem cell recruitment in mice

AU - Nair, A.

AU - Shen, J.

AU - Lotfi, P.

AU - Ko, C. Y.

AU - Zhang, Chengcheng

AU - Tang, L.

PY - 2011/11

Y1 - 2011/11

N2 - Autologous stem cells, recognized as the best cells for stem cell therapy, are associated with difficult extraction procedures which often lead to more traumas for the patients and time-consuming laboratory work, which delays their subsequent application. To combat such challenges, it was recently uncovered that, shortly after biomaterial implantation, following the recruitment of inflammatory cells, substantial numbers of mesenchymal stem cells (MSC) and hematopoietic stem cells (HSC) were recruited to the implantation sites. These multipotent MSC could be differentiated into various lineages in vitro. Inflammatory signals may be responsible for the gathering of stem cells, since there is a good relationship between biomaterial-mediated inflammatory responses and stem cell accumulation in vivo. In addition, the treatment with the anti-inflammatory drug dexamethasone substantially reduced the recruitment of both MSC and HSC. The results from this work support that such strategies could be further developed towards localized recruitment and differentiation of progenitor cells. This may permit the future development of autologous stem cell therapies without the need for tedious cell isolation, culture and transplantation.

AB - Autologous stem cells, recognized as the best cells for stem cell therapy, are associated with difficult extraction procedures which often lead to more traumas for the patients and time-consuming laboratory work, which delays their subsequent application. To combat such challenges, it was recently uncovered that, shortly after biomaterial implantation, following the recruitment of inflammatory cells, substantial numbers of mesenchymal stem cells (MSC) and hematopoietic stem cells (HSC) were recruited to the implantation sites. These multipotent MSC could be differentiated into various lineages in vitro. Inflammatory signals may be responsible for the gathering of stem cells, since there is a good relationship between biomaterial-mediated inflammatory responses and stem cell accumulation in vivo. In addition, the treatment with the anti-inflammatory drug dexamethasone substantially reduced the recruitment of both MSC and HSC. The results from this work support that such strategies could be further developed towards localized recruitment and differentiation of progenitor cells. This may permit the future development of autologous stem cell therapies without the need for tedious cell isolation, culture and transplantation.

KW - Autologous stem cells

KW - Flow cytometry

KW - Foreign body response

KW - Hematopoietic stem cells

KW - Mesenchymal stem cells

UR - http://www.scopus.com/inward/record.url?scp=80053574516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053574516&partnerID=8YFLogxK

U2 - 10.1016/j.actbio.2011.06.050

DO - 10.1016/j.actbio.2011.06.050

M3 - Article

VL - 7

SP - 3887

EP - 3895

JO - Acta Biomaterialia

JF - Acta Biomaterialia

SN - 1742-7061

IS - 11

ER -